1. LISA-MARIE CRICHTON & ASSOCIATES
MARINE BIOTECHNOLOGY MANAGEMENT CONSULTANCY WITH SIGNIFICANT PARTNERS THE SOUTH PACIFIC
REGION IN COMMERCIAL COLLABORATIONS
2. MARINE BIOTECHNOLOGY MANAGEMENT CONSULTING WITH SIGNIFICANT PARTNERS THE SOUTH PACIFIC REGION
& COMMERCIAL COLLABORATIONS
A Private Sector Marine Biotechnology Management Consultant working in collaboration with Significant Partners from the South
Pacific Region and leading local and International Experienced World-Class Experts & Associates. We collaborate in innovative,
commercially viable, sectors of the Marine Biotechnology industry in marine biotechnology product scientific research,
bioprospecting towards the discovery of“new-to-science” products for development and commercialisation.
We plan, design, manage and implement an integrated strategic approach to commercial collaborations in marine biotechnology for
“new-to-science” biodiscovery, from scientific research and development, biotechnological processing and production through to
commercialisation. We collaborate in commercial partnerships for marine scientific research to develop and commercialise “new-
to-science” marine biotechnology products for sales to commercially viable and emerging global markets, predominantly in Asia,
Europe, Scandinavia, USA and South America and selected emerging markets worldwide.
We specialise in a range of marine biotechnology products including pharmaceuticals, vitamins, minerals, supplements, cosmetics,
hair and beauty products and accessories and products in the medicinal, agricultural and industrial sectors and the multitude of
associated industries from production and manufacturing to global supply chain distribution.
We integrate our global commercialisation strategies to suit each marine biotechnology product. This includes authentication,
efficacy, packaging, labelling compliance with each individual countries compulsory Patent requirement for health and safety and
relevant international export market entry requirements for international Government products standards.
3. MANAGEMENT CONSULTING IN PRIVATE SECTOR COMMERCIAL COLLABORATIONS WITH SIGNIFICANT PARTNERS IN
MARINE BIOTECHNOLOGY NEW PRODUCT DEVELOPMENT
We work with a broad rangeof significant partners and associates in commercial development in the Marine Biotechnology industry.
With a multitude of professionals working in associated sectors of marine biotechnology, including Innovation and increased
efficiency, efficacy, health and safety measures and the best scientific research methodologies and technologies with applications
and uses to accelerate the quality and effectiveness of “new-to-science” marine biotechnology products.
We initiate, plan, design, develop, implement, manage and coordinate, potential commercial collaborations with significant partners
in marine biotechnology products industry and the entire process frombiodiscovery to commercialisation, through integrated, multi-
faceted strategies and synergies of mutually agreed cooperation.
We strategize, prioritise, organise and coordinate commercial collaborations in consortiums between significant partners, private
sector entrepreneurs, private sector investors and biotechnology companies, scientific research and development experts. We
consult and negotiate the necessary and compulsory components, formalities, and protocols. We coordinate multi-faceted national
and regional, sub-regional, inter-regional and international complex structural and lateral synergies for each individual commercial
activity between significant partners and associated consortiums in commercial collaborations.
4. MANAGEMENT CONSULTING IN COMMERCIAL COLLABORATIONS & CONSORTIUMS
COMMERCIAL COLLABORATIONS & CONSORTIUMS
ProspectiveExpressions of Interestin Commercially Viable Enterprises in Marine Biotechnology ProductDevelopment
Consultations for potential commercial collaboration in marine biotechnology development
Collaboration, development, planning and implementation of various activities to achieve definitive action in commercially
viable propositions fromthe marine biotechnology privatesector industry
Commercial Collaborations, Partnerships and Consortiums in Marine Biotechnology in the South Pacific
Entrepreneurial PrivateSector Initiatives in Collaborations for Marine Biotechnology CommercialProducts
Commercial Feasibility Studies and Assessments for ProspectiveSignificantPartners and Investors
ConsortiumStakeholders Projects including Design, Management and Implementation
Business Management and Administration, Audits, Transparency and Accountability
Business Intelligence and IndustryTrends for CommercialMarine Biotechnology Products
Collaborative innovations in marine biotechnology development, genomics, molecular and chemical engineering, bioreactor
design bioprocess engineering and transgenic production, combined with efficient processing and production applications
necessary to meet the needs of both discovery and bulk production of novel marine bio products
Working in partnership with a global connections inventing a new generation of tools and processes that will enable a greater
understanding of the ocean and its resources and lead to the discovery of new bio products for the future, and designing methods
for their sustainable development.
MARINE BIOTECHNOLOGY SCIENTIFIC RESEARCH AND DEVELOPMENT
5. MARINE BIOTECHNOLOGY RESEARCH AND DEVELOPMENT & PRIVATE SECTOR INVESTMENTS
We are experts in our field and understand the importance of marine biotechnology research and development (R & D). We have
local and international specialists and experts, technologies and resources strategically collaborating in a multi-disciplinary and
holistic approach to marine biotechnology research and development, as an essentially important part of the bio-discovery process.
Based on the a multitude of multi-sectoral disciplines associated with scientific marine research, from collection processes, multiple
screening and research and development methodologies.
These new technologies, have completely transformed scientific research and “new-to-science” discovery processes from 10 – 20
years of research in the laboratory, to a few seconds, with marine biotechnology products commercialised and patented within 2/3
years.. The impact of these innovations in the scientific and biotechnology community, has enabled faster, effective, safe and
healthy quality marine biotechnology products. The number of patents in marine biotechnology products is increasing, as the ratio
of new products or products with novel uses and characteristics. Combined with other biotechnology equipment has become more
commercially viable to prospective investors and collaborators, as the returns are much faster
This includes global spheres of influence in the marine biotechnology network of the world’s experienced, pioneering and leading
Academics, Scientists, Researchers and Biotechnology Product developers. With years of relevant experience in the South Pacific
Region and internationally, up to date with the latest industry developments including innovations and advances in technologies
used for various applications in Marine Biotechnology Research and Development (R & D), necessary.This, coupled with a genuine
understanding of the challenges, needs and objectives of our prospectiveclients, ensures wedeliver insightful and strategic solutions
in a cost effective commercial and efficient way.
MARINE BIOTECHNOLOGY RESEARCH & DEVELOPMENT &
COMMERCIAL PRODUCT DEVELOPMENT
6. We adviseprospectivecommercial partners to develop and formulate a commercial collaborative contractto negotiate with
Significant Partners the South Pacific region. We bring together leading academics, scientific research and development industry,
the Privatesector, Small to Medium Size Enterprises (SMEs), Entrepreneurs, leading Biotechnology Companies and Associates
fromMarine Biotechnology Organisations to facilitate and implement strategies and managementplans for the development of
commercial “new-to-science” marine biotechnology products.
We develop, prepare, consult, adviseand negotiate recommendations for commercial contractual collaborations.
We facilitate consultations and negotiations in conjunction with expert specialised professionalscientific, institutional and expert
advice to ensurecompliance with all regional compulsory requirements, relevantprotocols, Licences, Permits, Intellectual
Property Rights (IPRs), Patents WTO Trade, Environmentand Biotechnology international regulations, including processing,
packaging and labelling to international standards. This is essentially a commercial, private sector export-driven business.
We integrate the South Pacific Region’s complex, synergies in National and Regional Legal and Regulatory Frameworks including
Regional and Multi-lateral Agreements and Conventions including the United Nations Convention on the Law of the Sea (UNCLOS)
and the Convention on Biological Diversity (CBD), the InternationalSeabed Authority (ISA) and GlobalOcean Spatial Planning and
uses.
We cover an extensive rangeof components necessary and compulsory RegionalLegal and Regulatory Frameworks consistent
with Trade Related Intellectual Property Rights (IPRs), Certificate of Origin and WTO regulations for contract formulation to
negotiation.
GLOBAL MARINE BIOTECHNOLOGY INDUSTRY AND THE SOUTH PACIFIC REGION
7. Discovery of “new-to-science” ingredients sourced from biologically rich and diverse endemic marine ecosystems represents one of
the most promising and highly visible outcomes of marine biotechnology research. Biochemical produced by marine invertebrates,
algae and bacteria, are very different than those from related terrestrial organisms and offer greater potential as new classes of
medicines. Examples of marine-derived medicinal, include an antibiotic from a fungi, two closely related compounds from a sponge
that treat cancer and a neurotoxin from a snail that has painkiller properties making it 10,000 times more potent than morphine
without the side effects. There are severalmore marine-derived or “sourced” compounds currently in clinical testing phases and it is
likely that many more will advance to the clinic as more scientists look to the sea for these biotechnological uses, utilising the latest
innovations in marine biotechnology technologies for efficacy, health and safety.In addition to new medicines, other uses for
marine-derived compounds include: Cosmetics (algae, crustacean and sea fan compounds), Nutritional Supplements (algae and fish
compounds), artificial bone (corals), and Industrial Applications (fluorescent compounds from jellyfish, novel glues from mussels,
and heat resistant Enzymes from deep-sea bacteria).
MARINE BIOTECHNOLOGY SCIENTIFIC RESEARCH AND DEVELOPMENT OF COMMERCIALISATION OF
8. MARINE BIOTECHNOLOGY PRODUCTS
STRATEGIES INTEGRATED INTO COMMERCIAL COLLABORATIONS
We make your bio-discovery and research and development process faster and more efficient. Using innovative analytical
instruments, essential laboratory equipment supplies and bio-tools for researchers working in the fields of antibodies, cultures,
biology, electrophoresis, genomics, proteomics and others for new-to-science marine biotechnology discovery research and
development (R&D) technologies. These technologies fast track the efficiency at which new to science gene species can be identified
and scientifically characterised for their application and uses and sector of marine biotechnology authenticated for scientific efficacy
and applications for commercial development into the “new biotechnology product”.
This will accelerate your application with our complete portfolio of analytical technologies and laboratory products spanning
research, discovery and production. With a strong focus on scientific research and development enabling scientists and laboratories
advancing “new-to-science” bio-discoveries with novel tools to innovate and support their pioneering efforts. R&D helps companies
navigate every step of the product development process to bring new products to market with morepredictability and efficiency and
technologies to authenticate their efficacy. With integrated strategies to maximise value adding potential, includes bio-additives
applications with other existing products. We minimise risk with up to date, accurate analysis and commercial insights in the
development planning and implementation phases. We provide practical strategies from world-class experts and work with the
new realities marine bioprospecting and marine biotechnology development through to commercialisation as part of our Private
Sector Commercial Collaboration.
MARINE BIOTECHNOLOGY PRODUCTS “SOURCED” FROM THE SOUTH PACIFIC
9. Marine biotechnology involves the discovery and application of products and processes derived from marine organisms. Marine
biotechnology's promising future reflects the tremendous biodiversity of the world's oceans and seas. The oceans and seas cover
more than three-quarters of the earth's surface. Marine organisms account for a major share of the Earth's biological resources.
Most major groups of living organisms are primarily or exclusively marine. Science has identified close to 200,000 species of marine
algae, animal bacteria, fungi and viruses, with perhaps as many as four times this number of organisms as yet unidentified. Tropical
marine environments harbour an especially wide diversity of animals and plants.
The scientific potential of marine biotechnology is reflected in the multitude of marine organisms’ and their unique qualities based
on need to adapt themselves to the extremes of temperature, pressure and darkness that are found in the world's seas. The
demands of the marine environment have led these organisms to evolve unique structures, metabolic pathways, reproductive
systems, and sensory and defence mechanisms.
Marine organisms are sessile and must employ sophisticated methods to compete for a place to anchor. Barnacles and mussels,
which depend on their ability to attach to solid surfaces for survival, have developed bio-adhesives that stick to all kinds of wet
surfaces. Research into the ways that marine organisms adhere to wet surfaces, or prevent other organisms from adhering to them,
is yielding useful new technologies.
SOUTH PACIFIC REGION MARINE BIOTECHNLOGY PRODUCTS INDUSTRY COMMERCIAL POTENTIAL &
10. EXPORT DRIVEN GLOBAL MARKET INDICATORS
The potential to generate significant wealth and the equitable and sustainable management of these new revenue streams,
capitalising on new employment opportunities and other indirect economic benefits is of critical importance. Opportunities for
commercial collaborations, partnerships, consortiums with the South Pacific Region.
The number of patents on marine biotechnology industry products in the following industry is substantial and an economic indicator
of the unprecedented commercial potential of the unique marine genetic resources of the South Pacific Region. Patented products
sourced and derived from the South Pacific region includes ingredients and “new-to-science” bioactive ingredients with unique
applications includes from the following industries:
Pharmaceutical industries and associated sectors
Cosmeceutical industries and associated sectors, beauty products, cosmetics, anti-aging,
Nutraceuticals for nutrition, supplements, vitamins, naturopathy, remedial, pain relief, complementary
Agricultural products and multitude of associated sectors
Industrial products and multitude of associated sectors
MARINE BIOTECHNOLOGY PRODUCTS IN THE COSMETICS INDUSTRY
11. MARINE BIOTECHNOLOGY PRODUCTS FOOD PROCESSING, PRODUCTION & PRESERVATION
MARINE BIOTECHNOLOGY PRODUCTS PHARMACEUTICALS VITAMINS AND SUPPLEMENTS
With successful “new-to-science” marine genetic resources, their microorganisms and the capabilities of the latest innovations in
multiple screening of sampling, interpretation of characterisation and potential scientific applications and uses, screen with more in
depth and higher probability of success. Utilising biotechnology research and development technologies, for a multitude of scientific
purposes in the development of new products, including synthesization, production and manufacturing technologies and
capabilities.
COMMERCIAL COLLABORATIONS AND CONSORTIUMS WITH THE SOUTH PACIFIC REGION SIGNIFICANT PARTNERS IN MARINE
12. BIOTECHNOLOGY INDUSTRY COMMERCIAL CONTRACTUAL AGREEMENTS
We bring together leading academics, scientists and research and development industry, private sector and biotechnology
companies and Small to Medium Size (SMEs), Entrepreneurs, leading Biotechnology Companies and Associates from marine
biotechnology organizations to encourage the development of commercial marine biotechnology.
We develop, prepare, consult positions and advise and negotiate recommendations for commercial contractual collaborations.
Facilitate consultations and negotiations in conjunction with expert specialised legal advice to ensure compliance with all regional
compulsory requirements, relevant protocols, licences, permits, intellectual property rights (IPRs), patents WTO regulations
Advise prospective commercial partners in the development and formulate a commercial collaborative contract to negotiate with
Significant Partners.
We integrate the South Pacific Region’s complex, synergies in Regional and National Legal and Regulatory Frameworks for
compliance.
We cover an extensive range of components necessary for contract formulation to negotiation.
COMMERCIAL COLLABORATIONS WITH SIGNIFICANT PARTNERS IN MARINE BIOTECHNOLOGY
13. Prospective collaborative partnership initiatives in marine biotechnology commercial research and development activities and
projects (and each of its components) have the following details: (variable) an example or guideline:
1. Commercial Feasibility studies and Commercial Strategy Recommendations
2. Project information (Description of proposed commercial activity, aims and objectives, resources, input/output and
legalities)
3. Companies using research on genetic resources (Biotech Company)
4. Research organizations working with companies (R & D Institutions)
5. Parties approving/sponsoring relevant research (Financial Arrangements)
6. Access Benefit sharing terms (Incentives and Investment Strategy)
7. Patents or other forms of Intellectual Property (IPRs) for Licencing (mutual protection)
8. Common and scientific names of the source organism (Certified)
9. Geographical area where the organism was collected (Authenticated)
10.Publications (depending on Private or Public Arrangements and Contractual)
11.Databases (as per Contractual mutual Agreements for Private or Publicly funded)
12.Commercialized products (Commercial Marketing and Sales Arrangements)
With world-class experienced industry experts and specialists, our integrated consulting teams bring you sustainableimplementable
strategies that integrate a multitude of relevant components in the complex global marine biotechnology industry and consistent
with World Intellectual Property Rights (WIPO),TradeAgreements, Regional and Multilateral EnvironmentalAgreements (MEA) s
and World Trade Organisation (WTO) standards.
Itis essentially consistentrelevant National and Regional South Pacific Region Private Sector and TransnationalBusinesses and
InternationalGovernments; Regional Organisations includethe following compulsory components:
14. 1. Precautionary Principle
2. Prior Informed Consent
3. Traditional Knowledge (TK)
4. Interpretation
5. Definitions
6. Environmental ImpactAssessments(EIA)
7. Multi-lateral Environmental Agreements (MEA)
8. Regulatory Legal Rules and Frameworks (RLRF)
9. Commercial Partnerships in Areas beyond National Jurisdiction
10.Biotechnology Health and Safety Standards
11.Certificate of Origin (CO)
12.Access and Benefit Sharing (ABS)
13.Mutually Agreed Terms (MAT)
14. Intellectual Property Rights (IPRs)
15.Material Transfer Agreement(MTA) and IPRs
16.Best Standard Practises (BSP)
17. Intellectual Property Rights (IPRs) and
18. Trade Related Intellectual Property Rights (TRIP)s
19.Patents, Royalties and Revenue Arrangements
20.Licencing and Co-Licencing Collaborative Arrangements
21.Trade Related Intellectual Property Rights (TRIP)s and Patents
Including a range of other relevant components depending on the complexity and variability of the Commercial Agreement.
Collaboration in Marine Biotechnology Industry Development Activities are already mapped out and reaffirmed in both the
Convention on Biological Diversity (CBD) and the United Nations Convention on the Law Of the Sea, compared to other geographic
biologically diverse parts of the world. In a unique situation that allows the mutually complementary established frameworks for
15. collaboration to be implemented into a series of Actions Plans with mutual economic benefit, and potentially commercially viable
enterprise opportunities for all stakeholders.
Legally binding provisions as referred to in the United Nations Convention on the Law of the Sea (UNCLOS) and the United Nations
Convention on Biological Diversity (CBD) With specific reference to the following Articles contained in the United Nations Convention
on the Law of the Sea (UNCLOS) consistent with South Pacific Regional Conventions integrated into the final text includes:
Maps of UNCLOS regions and Legal Status
Limits of the Territorial Seas and Jurisdiction
Ownership and Control
Exclusive Economic Zones (EEZs)
Regime of the Island
Principles Governing the Area
Development of Resources of the Area
Protection and Preservation of the Marine Environment
Global and Regional Cooperation and InternationalTrade and Investment
Technical Resources, Technology Transfer, Training and Capacity Building
Monitoring and Environmental Assessment
Marine Scientific Research within the Consistentwith the South Pacific’s Global Ocean Spatial
Planning
Conduct of Scientific Research
Scientific Research Institutions or Equipment in the Marine Area
Development and Transfer of Marine Technology
General Provisions of InternationalCooperation and Collaboration in Marine Biotechnology
Adviseand consulting on the feasibility of internationally agreed guidelines on environmentalregulations, health and safety in
marine biotechnology we integrate:
16. Risk assessment and risk mitigation and management and the feasibility of guidelines which facilitates national legislation
Clarification of the relationship between the legal framework of Intellectual Property Rights (IPRs) and relevant Conventions
referring to partnerships, collaborations in Marine Biotechnology the United Nations Convention on the Law of the Sea
(UNCLOS) and the Convention on Biological Diversity (CBD) and the InternationalSea Bed Authority (ISA) and the Pacific Island
Countries and Pacific Island Country Territories with their security from France and the USA
Further develop, as necessary, the existing safety procedures to promote scientific development and categorization in the
areas of risk assessment and risk management (information requirements; databases; procedures for assessing risks and
conditions of release; establishment of safety conditions; monitoring and inspections, taking account of ongoing national,
regional and international initiatives and avoiding duplication wherever possible
Compile, update and develop compatible safety procedures into a framework of internationally agreed principles as a basis for
guidelines to be applied on safety in biotechnology, including consideration of the need for and feasibility of an international
agreement, and promote information exchange as a basis for further development, drawing on the work already undertaken
by international or other expert bodies
Deep Sea Mining Contractual Agreements in the South Pacific Region
17. Management Consultancy Advice and Services consistent with the requirements for Commercial Collaborations for Commercial Cont ractual
Collaborations for Licences and Permits and to obtain Mining of South Pacific Region Minerals and Marine Resources includes:
Consistent with facilitating existing enabling mechanisms that safeguard the interests of the country and its people while at the
same time encouraging and facilitating mutually beneficial investment in both the Marine Biotechnology industry and Deep Sea
Minerals (DSM) exploration and mining in the region.
Certificate of Origin
Prior Informed Consent
Regional Legal and Regulatory Frameworks (RLRF)
Regulatory Frameworks for CommercialCollaborations in areas Beyond Nations Jurisdiction with the EEZs and CS
Compliance and Consistency with all National and Regional Conventions and Multilateral Agreements and Conventions
18. Regional Legal and Regulatory Frameworks and Conventions consistentwith the UN Convention on the Law of the Sea
WTO Commercial Agreements and compulsory requirements
Development of Strategy Exploration, Research, Development and mining of Specific Mining Area
Obligations Prior to submit Mining Application presentation of the following compulsory documentation
Commercial Feasibility Study
Environmental ImpactAssessment(EIA) and EnvironmentalManagement plan
Environmental Liabilities and Responsibilities
Social impact Assessmentand Economic Benefits
Financing Management, Revenue Recognition, Royalties, Transparency and Accountability
Proposed Participating Companies “entities” or consortia
Exclusivity the rights granted to the Company to conduct Deep Sea Mining operations are exclusive within the Mining Area
and include the exclusive right to mine and market Minerals extracted fromthe Mining Area. The State undertakes not to
grant any rights to prospectfor or to mine minerals in the Mining Area or market minerals fromthe Mining Area to any third
party during the Term of a Licence and Agreement
Grant of Access Rights Terms and Conditions and Obligations
Grant of Mining Development rights and Contractual Mining Agreements with National and Regional Regulatory Authorities
Existing Rights and Ownership and Controlof Mining Permits under the Law of the Sea
Definitions and interpretation of Mining Agreement
Duration of Mining Agreement and Termination Obligations
Financial Management, Revenue Recognition and Conditions for Payment of Royalties
Royalty and Revenue Recognition on any other mineral or resourcematerial including “new-to-science” marinegenetic
resources sourced fromtheArea
Disputes and Mechanisms regarding Royalty Payments
19. Production Statements with quantative specifications of quantity and type of mineral resources and other material extracted
fromdeep-sea mining area and volume output
Customs Duties
Insurance
Security
Mining or PrivateSector Business Company rights
Company and Development Obligations
Health & safety
Mining Closure/Post-Closureobligations
ClosurePlan and Closureobligations
Guarantees for Closure expenses
Post-ClosureMonitoring
The Company shall in Consultation with local community leaders, develop and implement a post-closuremonitoring
committee, with the mandate to supervisethe monitoring of geophysicalstability, water quality, and rehabilitation of
contaminated sites and restoration of land for post-closureuse. The post-closuremonitoring shalltake place for a period after
the cessation of Commercial production, the length of which shallbe agreed in the Closureplan.
Cooperation, Dispute resolution and Arbitration
Access following Expiration or Termination of Licence, Permit or Contractual Agreement
21. We are the PRIVATESECTOR with an Integrated Strategic Global Commercial expert connections in all fields of Marine Biotechnology
from Academics, Scientific Research and Development Experts, Biotech Companies, Marine Biotech Technologies, Innovative
Financial Arrangements Options and Innovative Marine Biotechnologists and Corporate Strategic Alliances to maximise global sales
using our global marine biotechnology products branding and “niche marketing” strategies includes. Our global established networks
and spheres of influence include our networks in:
AUSTRALIA & NEW ZEALAND: Surfers Paradise, Australia
SOUTH PACIFIC REGION: Apia, Samoa, Suva, Fiji, Noumea, New Caledonia, Tahiti (all 21 Pacific Island Countries)
ASIA: Hong Kong, Beijing, China, Singapore, Tokyo, Japan (and Asian regional networks)
EUROPE: London, Ireland, Scotland, Amsterdam, Holland, Paris, France, Geneva, Switzerland, Bonn, Germany
USA & CANADA: Ontario, Canada, New York, San Diego, San Francisco, California, Washington, USA
SOUTH AMERICA: Rio de Janeiro, Sao Paolo, Brazil, Uruguay, Paraguay,
SCANDANAVIA: Copenhagen, Denmark, Stockholm, Sweden, Oslo, Norway, Finland
GLOBAL COMMERCIALISATION FOR DIRECT SALES TO INTERNATIONAL MARKETS
22. GLOBAL COMMERCIALISATION OF “new-to-science” MARINE BIOTECHNOOGY PRODUCTS
Consultancy and Management Services integrated into our collaborative Agreements include planning, design and direct sales for
“new-to-science” Marine Biotechnology products for Global Commercialisation include:
Branding
Marketing
Advertising Campaigns
ProductLaunches
Direct Marketing and Sales to international markets
